A continuous glucose monitor is a small sensor worn on the arm or abdomen that samples the fluid under the skin every few minutes and streams a blood-sugar reading to your phone. In diabetes it is one of the better-supported tools there is: randomized trials show it lowers HbA1c and raises the time spent in range, and in people prone to dangerous lows it cuts severe episodes. In a metabolically healthy person the picture changes.
The device shows that the same meal moves two people very differently, an effect confirmed across large groups, but no trial has yet shown that eating to those readings makes a healthy person healthier. The glucose rises it displays after a meal are what a working body is supposed to produce.
Findings & Outcomes
What It Is
A continuous glucose monitor is a coin-sized patch with a fine filament sitting just under the skin, worn for ten to fourteen days and then replaced. It reads the glucose in the fluid between your cells every one to five minutes and sends the number, plus a trend arrow, to a phone or reader. For someone with diabetes it replaces a dozen fingersticks a day with a continuous picture, and that picture is what the trials below are built on. For someone curious about their metabolism it shows how meals, movement, sleep, and stress move a number that used to be invisible between clinic visits. This page separates the two uses, because the evidence behind them differs sharply, and grades each accordingly.
Anatomy of the Practice
1What the sensor actually reads
The filament does not touch blood. It sits in interstitial fluid, the watery space around the cells, where glucose arrives from the bloodstream a few minutes after it rises there. An enzyme on the filament reacts with glucose and produces a tiny electrical current the device converts into a reading.
2The lag between fluid and blood
Because glucose has to cross from blood into that fluid, the sensor reads a few minutes behind your actual blood level. In healthy volunteers the delay measured about five to six minutes at rest, and it stretches when glucose is rising or falling fast. A number that is climbing on screen has already climbed a little further in your blood, and a low reading during a rapid fall may lag the real low.
3Where the readings drift
Modern factory-calibrated sensors run an average error near nine percent against laboratory blood, close enough for tracking patterns and far looser than a lab result. Lying on the sensor can produce a false low, called a compression low, that vanishes when you roll off it, and the first day of a new sensor is often the least accurate.
How It Works
In diabetes the value comes from the pattern over time, not any single reading. Seeing the overnight drift, the meal that sends glucose highest, and the exercise that brings it down turns an abstract HbA1c into something a person can act on with their clinician, and it warns of a low (hypoglycemia) before symptoms arrive. This is why the diabetes trials work: the person and the prescriber get information that was not there before, and treatment adjusts around it. The machinery of how a meal raises glucose and how muscle and insulin bring it down sits on the insulin and glucose page, and managing the condition is covered on the type 2 diabetes page.
In a metabolically healthy person the same stream of numbers means something quieter than the marketing suggests. A rise after eating is the body working normally: glucose enters the blood, insulin rises, muscle and liver take it up, and the level returns to baseline within a couple of hours. Among the roughly one-quarter of normoglycemic people who show a "severe" glucotype, glucose reaches a range a chart would label prediabetic up to fifteen percent of the time and a diabetic range about two percent, with nothing wrong with them. The readings are accurate; the interpretation that every rise is damage is the part the evidence does not support.
What It Does
The findings below fall into two groups, and the gap between them is wide. In diabetes, monitoring lowers HbA1c, raises time in the target range, and cuts dangerous lows; those results come from randomized trials and sit at the top of the ladder. In metabolically healthy people, the monitor established one thing clearly: give a group the identical meal and their glucose responses vary widely, so a food that barely moves one person sends another climbing. That variation is well established, and it is the finding behind personalized-nutrition marketing. What no trial has shown is that a healthy person who eats to the monitor ends up healthier, loses weight, or avoids disease. The cards below are ordered by that logic, strongest evidence first.
A monitor is one of the best-supported tools in diabetes and, for a metabolically healthy person, a self-experiment whose long-term payoff has not been measured.
The Research & Studies
Everything here is based on the research we have collected and checked, sorted into groups and ordered with the strongest evidence first. Click any claim to open the studies behind it.
Blood Sugar
Type 1 diabetes on injections: a monitor lowered HbA1c about 0.6% more than fingersticks
Adults with type 1 diabetes who wore a monitor instead of testing with fingersticks lowered their long-term blood-sugar marker (HbA1c) by about 0.6 percentage points more than usual care, and spent less time in a dangerous low.
The DIAMOND randomized trial enrolled 158 adults with type 1 diabetes using multiple daily insulin injections, with baseline HbA1c between 7.5% and 9.9%. Over 24 weeks the continuous glucose monitoring group reduced HbA1c by 1.0% against 0.4% for the control group, an adjusted difference of -0.6% (95% CI -0.8% to -0.3%). Median time under 70 mg/dL dropped from 80 min/day (IQR 36-111) in controls to 43 min/day (IQR 27-69) with monitoring (P=.002). A 0.6% HbA1c reduction from a monitoring tool alone is large in this field.
The benefit here is well established. In type 1 diabetes on injections, a monitor is a mainstream tool, and its use belongs in a plan with a diabetes team.
The study · 1
Beck et al., effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial · JAMA 2017;317(4):371-378
Type 2 diabetes on intensive insulin: HbA1c fell about 0.3% more with a monitor
People with type 2 diabetes who used a lot of insulin lowered their HbA1c a little more with a monitor than with fingersticks, about 0.3 percentage points.
This arm of DIAMOND randomized 158 adults with type 2 diabetes, aged 35 to 79 (mean 60), on multiple daily insulin injections with baseline HbA1c 7.5% to 9.9%. The adjusted difference in mean HbA1c change favored monitoring at -0.3% (95% CI -0.5% to 0.0%), a smaller effect than in the type 1 arm, and most participants used the sensor daily or near-daily across the 24 weeks.
The gain is modest in this group; it is one input to insulin adjustment with a prescriber, not a standalone fix.
The study · 1
Beck et al., continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial · Ann Intern Med 2017;167(6):365-374
Type 2 diabetes on basal insulin: time in range rose to 59% from 43% with a monitor
People with type 2 diabetes on once- or twice-daily background insulin, cared for in ordinary primary-care practices, spent much more of the day in a healthy blood-sugar range with a monitor, 59% versus 43%, and their HbA1c dropped further.
MOBILE randomized 175 adults with type 2 diabetes treated with one or two daily injections of long- or intermediate-acting basal insulin and no mealtime insulin, in primary-care settings. Over eight months the continuous glucose monitoring group reached 59% time in the 70-180 mg/dL range against 43% for blood-glucose meter users, and HbA1c fell from 9.1% to 8.0% versus 9.0% to 8.4%, an adjusted difference of -0.4% (95% CI -0.8% to -0.1%; P=.02). The primary-care setting makes this closer to real-world use than specialist-clinic trials.
Time in range is the outcome that shifts most here; for someone on basal insulin, raise it with a clinician as a target alongside HbA1c.
The study · 1
Martens et al., effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: the MOBILE randomized clinical trial · JAMA 2021;325(22):2262-2272
The benefit tracks wear: adults using it six or more days a week lowered HbA1c about 0.53%
The monitor helps most when it is actually worn most days. In a trial across ages, adults who wore it six or more days a week improved their HbA1c, while younger people who wore it less did not see the same benefit.
The JDRF continuous glucose monitoring trial randomized 322 adults and children with type 1 diabetes on intensive therapy. Among adults aged 25 and over, HbA1c improved by a mean difference of -0.53% (95% CI -0.71 to -0.35; P<.001), and 83% of that group used the sensor at least six days a week. In younger age groups, where wear was lower, the HbA1c benefit did not reach significance. The effect tracks consistent wear, not occasional use.
Getting value from a monitor means wearing it most days; sporadic use is the common reason it fails to help.
The study · 1
Juvenile Diabetes Research Foundation CGM Study Group (Tamborlane et al.), continuous glucose monitoring and intensive treatment of type 1 diabetes · N Engl J Med 2008;359(14):1464-1476
Type 2 diabetes without insulin: HbA1c fell about 1.0% with intermittent wear and held for a year
Even people with type 2 diabetes not using insulin lowered their HbA1c a little more with a monitor worn on and off, and the improvement lasted about a year, without needing extra medication.
Vigersky and colleagues randomized 100 adults with type 2 diabetes not on mealtime insulin to intermittent real-time monitoring (four cycles of two weeks on, one week off) or fingerstick self-monitoring. Mean HbA1c reductions in the monitoring group were 1.0%, 1.2%, 0.8% and 0.8% at weeks 12, 24, 38 and 52, versus 0.5%, 0.5%, 0.5% and 0.2% in the fingerstick group (P=.04). The gain held after monitoring stopped and did not require intensified medication, suggesting the improvement came through behavior.
For non-insulin type 2 diabetes, an on-and-off wear pattern, not continuous use, captured the benefit in this trial and keeps cost down.
The study · 1
Vigersky et al., short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes · Diabetes Care 2012;35(1):32-38
The same meal moves people differently: glucose responses varied about 68% across 1,002 adults
Give a large group of people the exact same meal and their blood-sugar responses differ a lot, around 68% between individuals. The same food that barely moves one person can spike another.
The PREDICT study measured postprandial responses to standardized meals in 1,002 twins and unrelated healthy adults in the UK, validated in a US cohort of 100. Between-person variability was large: 103% for blood triglyceride, 68% for glucose and 59% for insulin. For the glucose response, meal macronutrients explained more of the variance (15.4%) than the gut microbiome (6.0%); for the fat response the pattern reversed (microbiome 7.1% versus macronutrients 3.6%). Genetics played a limited role. This is the observation behind personalized-nutrition marketing.
The variation is a reason population averages fit poorly to an individual; it is not, on its own, evidence that eating to your own responses improves health.
The study · 1
Berry et al., human postprandial responses to food and potential for precision nutrition · Nat Med 2020;26(6):964-973
In the severe-glucotype quarter of healthy people, glucose reached prediabetic ranges up to 15% of the time and diabetic 2%, with no disease
Among the roughly one-quarter of healthy people with a severe glucotype, glucose still climbed into a range a chart would call prediabetic up to 15% of the time, and diabetic about 2%, without anything being wrong. Rises after meals are normal physiology.
The glucotypes study put continuous monitors on adults spanning normal to prediabetic glucose regulation and found that glucose dysregulation was more common and varied than standard tests suggest. Among the roughly one-quarter of normoglycemic participants classified as a severe glucotype, glucose reached prediabetic ranges up to 15% of the time and diabetic ranges about 2%. The authors describe distinct patterns (glucotypes) of variability even among people considered normal, which reframes a post-meal rise as expected, not a sign of harm.
Read a single high-looking reading as ordinary physiology, not damage; sustained high glucose, the marker of diabetes, is the pattern that matters.
The study · 1
Hall et al., glucotypes reveal new patterns of glucose dysregulation · PLoS Biol 2018;16(7):e2005143
Prediabetes: a monitor modestly improved blood sugar across 23 studies, an early signal
In people with prediabetes, wearing a monitor was linked to modestly better blood sugar and to sticking with diet and activity changes, an early but promising signal.
Liao and colleagues pooled 23 studies of continuous glucose monitoring in 1,074 non-diabetic participants across 11 countries. Monitoring significantly improved mean blood glucose against controls (P=.03), and use was associated with greater behavioral adherence and specific dietary changes. The review separated the groups: glycemic benefit appeared in people with prediabetes but not in healthy normoglycemic participants, so the effect concentrates where blood sugar is already drifting.
In prediabetes a monitor may reinforce lifestyle change, but it works alongside diet and activity, not in place of them.
The study · 1
Liao et al., continuous glucose monitoring in non-diabetic populations: a systematic review of observational and interventional studies with meta-analysis · Eur J Med Res 2026
Counts once: this finding and 1 other here come from the same source, so they are one body of evidence, not separate confirmations.
Metabolically healthy people: no measured blood-sugar or weight benefit from wearing a monitor
In metabolically healthy people, pulling the studies together showed wearing a monitor did not meaningfully improve blood sugar and did not change weight.
The same systematic review of 23 studies in 1,074 non-diabetic people reported that while prediabetic participants saw a glycemic improvement, no appreciable glycemic benefit was observed in healthy normoglycemic populations, and no significant differences in BMI were found between monitoring and control groups. The authors note that standalone weight loss was unlikely without accompanying behavioral interventions, and that evidence on accuracy and glycemic variability in this group remains limited. No trial in this review measured a hard health outcome such as disease incidence or lifespan.
For a metabolically healthy person, treat a monitor as a curiosity or a short self-experiment rather than a health intervention, since a measured benefit has not appeared.
The study · 1
Liao et al., continuous glucose monitoring in non-diabetic populations: a systematic review of observational and interventional studies with meta-analysis · Eur J Med Res 2026
Counts once: this finding and 1 other here come from the same source, so they are one body of evidence, not separate confirmations.
Behavior Change
Added to a lifestyle program, a monitor lifted goal-setting and attendance in a 13-person pilot
Adding a monitor to a lifestyle program nudged people to track themselves more, set goals and show up more often, an early hint that the feedback can support behavior change.
Bailey and colleagues ran an 8-week randomized pilot in 13 adults with prediabetes or type 2 diabetes (7 control, 6 intervention). The group given real-time continuous monitoring showed significantly greater increases in self-monitoring behavior (P<.01), goal-setting (P=.01) and self-efficacy (P=.01), higher program attendance (P=.03), and were more likely to re-register for further programs (P=.048). Both groups improved waist circumference and fitness. The sample is tiny, so this is a signal to explore, not a settled effect.
As a short-term motivational aid alongside an actual lifestyle plan, a monitor may help engagement; the feedback can support the change, it does not create it.
The study · 1
Bailey et al., self-monitoring using continuous glucose monitors with real-time feedback improves exercise adherence in individuals with impaired blood glucose · Diabetes Technol Ther 2016;18(3):185-193
Getting the Most From One
Ways to Do It
This is a medical device, and the section below is about learning from it, not buying a particular one. If you have diabetes, its use belongs in a plan with your clinician, where the evidence is strongest. If you are healthy and curious, here is how to get something useful out of a short trial without turning it into a source of worry.
The strong results are in diabetes and in people at high risk of dangerous lows. If that is you, this is a conversation with your diabetes team, who can prescribe and interpret it. If you are metabolically healthy, treat what follows as curiosity, because no trial has shown a health payoff for you.
A single sensor lasts about two weeks. Wearing one for two to four weeks is enough to see your own patterns. Treating it as a permanent fixture spends money on a stream of numbers whose benefit in a healthy person has not been shown, so a defined experiment gives you the information without an open-ended subscription.
The useful questions are the repeatable ones: which meals consistently send you highest, whether a walk after dinner flattens the evening, how a poor night changes the next morning. One alarming-looking spike after one meal tells you little, since day-to-day noise and sensor error are large. The value is in what shows up again and again.
The monitor is most useful as feedback on an experiment you already wanted to run: a [walk after your largest meal](/go/integrative/practice/post-meal-walk), swapping refined carbohydrate for [whole foods](/go/integrative/practice/whole-foods), or moving your last meal earlier. Watching the number respond to a deliberate change is more informative than watching it drift.
A common trap is chasing a flat line by cutting out fruit, whole grains and other nourishing foods that happen to raise glucose, which are foods a healthy body handles well. If the readings start driving anxious eating or a shrinking list of allowed foods, that is the signal to take the sensor off. The aim is information, not a smaller diet.
Go Deeper
- Type 2 diabetes: where monitoring sits among diet, movement and medication, and where its evidence is strongest.
- Post-meal walk: the change most worth testing on a monitor, and one that moves the number the same evening.
- Insulin and glucose: the physiology underneath every reading, and why a rise after eating is the body working.
- Whole foods: the dietary shift a curious self-experiment is most likely to reward.
The Chinese Medicine View
Chinese medicine has no glucose number, and does not work from one. Digestion here belongs to the Spleen and Stomach: the Stomach receives and ripens the meal, and the Spleen transforms it and distributes what is useful. Sweet flavor is understood to enter the Spleen, and in small amounts to support it, while a diet heavy in sweet, rich and greasy food is said to overwhelm that transforming function and generate Damp and Phlegm, read in heaviness after eating, fatigue, a thick tongue coat and a swollen tongue body. This is a description of a person and a pattern over time, not a measurement of the blood after one meal, and the two frames should not be forced onto each other.
There is a loose parallel here, and it is easy to overstate. The tradition has always held that the same food suits one constitution and burdens another, that what nourishes a robust person can generate Damp in someone whose Spleen is weak. The monitoring finding that identical meals move different people differently sits alongside that idea without confirming it and without having been predicted by it: one measures interstitial glucose over hours, the other assesses a whole constitution over months and years. A practitioner would still ask how you feel after eating, look at your tongue, and take your pulse, and treat the pattern in front of them.
Cautions For This Practice
Extra restraintEverything to be aware of is here, in one place. This practice suits most healthy people; a few situations call for real care.
Type 1 diabetes with unfelt lows: a monitor cut severe low-sugar events from 34 to 14
The IN CONTROL crossover trial studied 52 adults (aged 18 to 75) with type 1 diabetes and impaired awareness of hypoglycemia. During continuous monitoring, time in normoglycemia was 65.0% (95% CI 62.8-67.3) versus 55.4% (53.1-57.7) with self-monitoring, and severe hypoglycemic events fell from 34 to 14 (P=.033). Impaired awareness makes lows dangerous because the usual warning symptoms are absent, and the sensor supplies the warning the body no longer gives.van Beers et al., continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial
The sensor lags real blood sugar about five to six minutes, longer when glucose moves fast
Basu and colleagues used a glucose tracer in eight healthy fasted volunteers to measure the physiological time lag from the intravascular to the interstitial compartment, finding a mean of 5.3 to 6.2 minutes. At rest this delay is small enough not to impair sensor use, but during rapid rises or falls the reading lags the real blood level further. This is why a fast-falling reading can understate an approaching low and a climbing reading has already climbed more in the blood.Basu et al., time lag of glucose from intravascular to interstitial compartment in humans
It is a tracking tool, not a diagnosis
A monitor does not diagnose diabetes or prediabetes, and its readings are not the numbers those diagnoses are made on. Diagnosis rests on a fasting blood sample, an HbA1c or a glucose tolerance test done in a laboratory. If the trend on a sensor worries you, that is a reason to ask a clinician for a proper blood test, not a result to act on by yourself.
Do not treat a number you do not trust
Because the sensor reads a few minutes behind your blood and drifts by around nine percent, a single reading that does not match how you feel deserves a fingerstick before you act on it. This matters most for anyone taking insulin or other glucose-lowering medication: if a low reading and your symptoms disagree, confirm with a fingerstick, and if you feel a low, treat it whatever the sensor says.
Watch for anxiety and over-restriction
In people without diabetes the readings can drive worry about ordinary meals and a steadily shrinking list of foods someone feels able to eat. Fruit, whole grains and legumes raise glucose and are foods a healthy body handles well. If a monitor is pushing eating toward fear or restriction, that is a reason to stop wearing it.
Skin reactions to the adhesive
The adhesive can cause itching, redness or a rash where the sensor sits, and reactions tend to build with repeated use. Rotating the site, letting the skin recover between sensors, and stopping if the skin breaks down are the usual measures. A spreading or blistering reaction is worth a clinician looking at it.
Start slow, be smart, read the research, and consult a professional if you have any concerns. This is here to inform your choice, not make it for you.
Common Questions
Does a continuous glucose monitor help if I do not have diabetes?
There is no trial showing a health payoff for a metabolically healthy person. A systematic review of 23 studies in people without diabetes found no appreciable improvement in blood sugar and no change in weight from wearing one. It can still be an interesting way to see how your own body responds to meals and movement, which is a reasonable curiosity, but the current evidence does not put it in the same category as its use in diabetes.
Are glucose spikes after meals bad for me?
In a person with normal blood sugar, a rise after eating is what is supposed to happen, and it comes back down within a couple of hours. When researchers monitored healthy people, the roughly one-quarter with a "severe" glucotype reached ranges a chart would call prediabetic up to fifteen percent of the time, with nothing wrong. The idea that every spike is doing damage is not supported by the evidence; the concern belongs with sustained high glucose, which is what diabetes is.
Why do two people get different readings from the same meal?
Because the response to food differs from person to person. In a study of over a thousand adults, glucose responses to identical meals varied by around 68 percent between people, shaped by habitual diet, the gut microbiome, sleep, and activity. This is the finding behind personalized nutrition. What has not been shown is that eating to smooth out your own responses makes you healthier.
How accurate are these sensors?
Accurate enough to track patterns, not a substitute for a lab test. A modern factory-calibrated sensor runs an average error near nine percent against laboratory blood. It also reads a few minutes behind your actual blood glucose, since it samples the fluid under the skin, and that lag grows when glucose is moving fast. For following trends this is fine; for a number you would act on medically, confirm with a fingerstick.
How long should I wear one if I am just curious?
Two to four weeks is usually enough to see your repeatable patterns, and a single sensor lasts about two weeks. Wearing one indefinitely spends money on a stream of numbers whose long-term benefit in a healthy person has not been measured. A short, defined experiment, ideally testing a change you were going to make anyway, gets you the useful information without turning your eating into a project.
Explore Related
Other pages this one connects to, by the evidence they share, the outcomes they touch, and the ground they cover.
All 12 sources on this page independently checked and cross-referenced.
Thomas Dehli, Founder & Editor, Sacred Lotus
Sacred Lotus has published Chinese medicine reference material since 2001. Integrative pages are held to the same standard as the herb and formula library: cite the source, grade the claim at its real strength, and say where the research has not looked. This page is educational and it is not medical advice. Last reviewed and updated August 9, 2026.
Evidence strength
How confidently the research supports a claim. Strength describes the evidence, not our endorsement.